HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1-3

Query Trace: Disease Progression and BID[original query]

A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). European journal of cancer (Oxford, England : 1990) 2015 Dec 54 11-17. Flinn Ian W, Bartlett Nancy L, Blum Kristie A, Ardeshna Kirit M, LaCasce Ann S, Flowers Christopher R, Shustov Andrei R, Thress Kenneth S, Mitchell Patrick, Zheng Fred, Skolnik Jeffrey M, Friedberg Jonathan Similar articles in PubMed
Efficacy and safety of olaparib monotherapy in germline BRCA1/2 mutation carriers with advanced ovarian cancer and three or more lines of prior therapy. Gynecologic oncology 2015 Dec . Domchek Susan M, Aghajanian Carol, Shapira-Frommer Ronnie, Schmutzler Rita K, Audeh M William, Friedlander Michael, Balmaña Judith, Mitchell Gillian, Fried Georgeta, Stemmer Salomon M, Hubert Ayala, Rosengarten Ora, Loman Niklas, Robertson Jane D, Mann Helen, Kaufman Bel Similar articles in PubMed
Phase I/II trial of the combination of midostaurin (PKC412) and 5-azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome. American journal of hematology 2015 Apr 90 (4): 276-81. Strati Paolo, Kantarjian Hagop, Ravandi Farhad, Nazha Aziz, Borthakur Gautam, Daver Naval, Kadia Tapan, Estrov Zeev, Garcia-Manero Guillermo, Konopleva Marina, Rajkhowa Trivikram, Durand Menda, Andreeff Michael, Levis Mark, Cortes Jor Similar articles in PubMed